Addressing limitations of single GON blockade treatment and repetitive intervention with GON block or onabotulinum toxin A in chronic migraine- part 2 of three men in a boat study
-
Published:2024-05
Issue:
Volume:240
Page:108242
-
ISSN:0303-8467
-
Container-title:Clinical Neurology and Neurosurgery
-
language:en
-
Short-container-title:Clinical Neurology and Neurosurgery
Author:
Karaoğlan Mustafa
Reference27 articles.
1. Quality of life in primary headache disorders: a review;Abu Bakar;Cephalalgia Int. J. Headache,2016
2. Headache Classification Committee of the International Headache Society (IHS) The International Classification of Headache Disorders, 3rd edition. (2018). Cephalalgia: AnInternational Journal of Headache, 38(1), 1–211.https://doi.org/10.1177/0333102417738202.
3. Global, regional, and national burden of migraine and tension-type headache, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016;Lancet Neurol.,2018
4. A comparison of the clinical efficacy of GON block at the C2 level and GON block at the classical distal occipital level in the treatment of migraine;Karaoğlan;Clin. Neurol. Neurosurg.,2022
5. Comparison of the clinical efficacy of bilateral and unilateral GON blockade at the C2 level in chronic migraine;Karaoğlan;Neurol. Sci.,2022